NUHS Singapore embarks on holomedicine research to improve medical diagnosis

Studies and clinical validation trials will be necessary before adopting this holomedicine solution as a main clinical method.

Singapore’s National University Health System (NUHS) has launched a research and development program to explore the use of mixed reality (MR) technology in clinical care. The research program hopes to support the development of next-generation clinical applications and improve patient safety.

This would augment clinical processes and improve undergraduate and postgraduate teaching. While the use of holographic technology in operating theaters is still nascent, NUHS hopes to apply it in multiple areas of surgery.

“Holomedicine exploits the concept of RM not only to augment our physical environment, but allows interaction with virtual objects superimposed on the real world. Virtual objects can also be manipulated in relation to the real world using natural gestures of the hand,” explained Dr. Gao Yujia, Associate Consultant in the Division of Hepatobiliary and Pancreatic Surgery at National University Hospital (NUH) and Holomedicine Program Manager at NUHS.

A team of NUH neurosurgeons has initiated a study to assess the feasibility of using holographic technology to spatially locate brain tumors during patient operations.

The NUHS team, in collaboration with the Engineering Design & Innovation Center at the Faculty of Engineering, National University of Singapore (NUS), has also been awarded a $100,000 grant from the Engineering Medicine Fellowship under NUHS and NUS in March 2021. The grant will enable the team to embark on a project in real-time volumetric rendering and ultrasound positioning. NUHS has collaborated with Microsoft and apoQlar in its holomedicine efforts. NUHS will continue to build on its existing partnerships and explore new collaborations with industry.